About 2 results found for searched term "BL-918" (0.237 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M21031 | BL-918 | ULK |
| BL-918 is a potent, orally active activator of UNC-51-like kinase 1 (ULK1) with EC50 of 24.14 nM and Kd of 0.719 μM. BL-918 induces cytoprotective autophagy for Parkinson's disease treatment. | ||
| M9346 | Pralsetinib | RET |
| BLU-667 | ||
| Pralsetinib (BLU-667) is a next generation highly potent, selective RET inhibitor with IC50 of 0.3-0.4 nM for WT RET, RET mutants V804L, V804M, M918T and CCDC6-RET fusion. | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.
